EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 377 filers reported holding EXELIXIS INC in Q2 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $12,238,443 | -30.4% | 544,657 | -26.5% | 0.03% | -31.7% |
Q1 2024 | $17,586,849 | +27.5% | 741,123 | +28.9% | 0.04% | +28.1% |
Q4 2023 | $13,797,633 | -65.0% | 575,141 | -68.1% | 0.03% | -69.8% |
Q3 2023 | $39,433,897 | +19.4% | 1,804,755 | +4.4% | 0.11% | +27.7% |
Q2 2023 | $33,032,686 | +83.9% | 1,728,555 | +86.8% | 0.08% | +62.7% |
Q1 2023 | $17,957,608 | +712.5% | 925,173 | +571.4% | 0.05% | +628.6% |
Q4 2022 | $2,210,184 | -59.6% | 137,792 | -47.6% | 0.01% | -61.1% |
Q2 2022 | $5,471,000 | -74.0% | 262,792 | -71.7% | 0.02% | -71.0% |
Q1 2022 | $21,050,000 | +64.4% | 928,561 | +32.6% | 0.06% | +129.6% |
Q4 2021 | $12,803,000 | -1.3% | 700,388 | +14.1% | 0.03% | -6.9% |
Q3 2021 | $12,977,000 | +2353.1% | 613,852 | +2733.8% | 0.03% | +1350.0% |
Q3 2020 | $529,000 | -97.9% | 21,662 | -98.0% | 0.00% | -98.4% |
Q2 2020 | $25,301,000 | +8114.6% | 1,065,742 | +5853.9% | 0.12% | +4066.7% |
Q1 2020 | $308,000 | -83.8% | 17,900 | -83.3% | 0.00% | -50.0% |
Q3 2019 | $1,898,000 | -66.9% | 107,296 | -60.0% | 0.01% | -68.4% |
Q2 2019 | $5,733,000 | +47.3% | 268,235 | +22.1% | 0.02% | +72.7% |
Q3 2018 | $3,892,000 | +6.2% | 219,624 | +29.0% | 0.01% | 0.0% |
Q2 2018 | $3,665,000 | -80.6% | 170,307 | -72.6% | 0.01% | -82.0% |
Q4 2017 | $18,878,000 | +67.5% | 620,979 | +33.5% | 0.06% | +52.5% |
Q3 2017 | $11,271,000 | -77.8% | 465,175 | -77.4% | 0.04% | -78.1% |
Q2 2017 | $50,692,000 | -39.4% | 2,058,125 | -46.7% | 0.18% | -35.1% |
Q1 2017 | $83,658,000 | +23.1% | 3,860,531 | -15.3% | 0.28% | +8.0% |
Q4 2016 | $67,956,000 | +111.4% | 4,557,738 | +81.4% | 0.26% | +125.0% |
Q3 2016 | $32,139,000 | +156.3% | 2,512,849 | +56.5% | 0.12% | +114.8% |
Q2 2016 | $12,539,000 | +108.4% | 1,605,443 | +6.7% | 0.05% | +86.2% |
Q1 2016 | $6,018,000 | +52.9% | 1,504,434 | +115.6% | 0.03% | +52.6% |
Q4 2015 | $3,935,000 | +76.0% | 697,693 | +75.1% | 0.02% | +72.7% |
Q3 2015 | $2,236,000 | +1185.1% | 398,492 | +230.4% | 0.01% | +1000.0% |
Q4 2014 | $174,000 | -15.1% | 120,603 | +99.4% | 0.00% | 0.0% |
Q2 2014 | $205,000 | -26.8% | 60,469 | -23.5% | 0.00% | 0.0% |
Q1 2014 | $280,000 | – | 79,038 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |